Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tiffany Chang, MD
Spark Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Orthopaedic Institute for Children
Los Angeles, California, United States
- Illinois Bleeding and Clotting Disorders Institute
Peoria, Illinois, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mississippi Center for Advanced Medicine
Madison, Mississippi, United States
- Weill Cornell Medicine
New York, New York, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Penn State Health
Hershey, Pennsylvania, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Jefferson University Hospitals
Philadelphia, Pennsylvania, United States
- Hemophilia Center of Western Pennsylvania
Pittsburgh, Pennsylvania, United States
- Virginia Commonwealth University School of Medicine
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jan 2019
- Primary completion
- 14 Oct 2020
- Completion
- 19 Jan 2023
- Last update posted
- 23 Feb 2024
- Registered enrollment
- 4
- Registry id
- NCT03734588
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.